公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study | Zhang J.; TSEN-FANG TSAI ; Lee M.-G.; Zheng M.; Wang G.; Jin H.; Gu J.; Li R.; Liu Q.; Chen J.; Tu C.; Qi C.; Zhu H.; Ports W.C.; Crook T. | Journal of Dermatological Science | 61 | 48 | |
2018 | Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study | Valenzuela F.; Korman N.J.; Bissonnette R.; Bakos N.; TSEN-FANG TSAI ; Harper M.K.; Ports W.C.; Tan H.; Tallman A.; Valdez H.; Gardner A.C. | British Journal of Dermatology | 47 | 43 |